475 related articles for article (PubMed ID: 1392745)
1. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
Nicolaides KH; Azar G; Byrne D; Mansur C; Marks K
BMJ; 1992 Apr; 304(6831):867-9. PubMed ID: 1392745
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of fetal nuchal translucency.
Jackson M; Rose NC
Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
[TBL] [Abstract][Full Text] [Related]
4. First-trimester fetal nuchal translucency thickness and risk for trisomies.
Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
[TBL] [Abstract][Full Text] [Related]
5. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.
Josefsson A; Molander E; Selbing A
Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169
[TBL] [Abstract][Full Text] [Related]
6. Fetal nuchal translucency thickness at 10-14 weeks' gestation and congenital diaphragmatic hernia.
Sebire NJ; Snijders RJ; Davenport M; Greenough A; Nicolaides KH
Obstet Gynecol; 1997 Dec; 90(6):943-6. PubMed ID: 9397108
[TBL] [Abstract][Full Text] [Related]
7. Increased nuchal translucency as a marker for fetal chromosomal defects.
Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
[TBL] [Abstract][Full Text] [Related]
8. Fetal karyotyping in twin pregnancies: selection of technique by measurement of fetal nuchal translucency.
Sebire NJ; Noble PL; Psarra A; Papapanagiotou G; Nicolaides KH
Br J Obstet Gynaecol; 1996 Sep; 103(9):887-90. PubMed ID: 8813308
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
[TBL] [Abstract][Full Text] [Related]
10. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
Hafner E; Schuchter K; Philipp K
Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203
[TBL] [Abstract][Full Text] [Related]
11. [Pregnancy outcome in fetuses with increased nuchal translucency thickness at 10-14 weeks of pregnancy].
Maymon R; Dreazen E; Tovbin Y; Weinraub Z; Herman A
Harefuah; 1999 Jun; 136(11):851-5, 916, 915. PubMed ID: 10955127
[TBL] [Abstract][Full Text] [Related]
12. Screening for fetal anomalies by ultrasound at 14 and 21 weeks.
D'Ottavio G; Meir YJ; Rustico MA; Pecile V; Fischer-Tamaro L; Conoscenti G; Natale R; Mandruzzato GP
Ultrasound Obstet Gynecol; 1997 Dec; 10(6):375-80. PubMed ID: 9476319
[TBL] [Abstract][Full Text] [Related]
13. First-trimester nuchal translucency and cardiac septal defects in fetuses with trisomy 21.
Hyett JA; Moscoso G; Nicolaides KH
Am J Obstet Gynecol; 1995 May; 172(5):1411-3. PubMed ID: 7755046
[TBL] [Abstract][Full Text] [Related]
14. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy.
Nicolaides KH; Brizot ML; Snijders RJ
Br J Obstet Gynaecol; 1994 Sep; 101(9):782-6. PubMed ID: 7947527
[TBL] [Abstract][Full Text] [Related]
15. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
[TBL] [Abstract][Full Text] [Related]
16. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester.
Souka AP; Krampl E; Bakalis S; Heath V; Nicolaides KH
Ultrasound Obstet Gynecol; 2001 Jul; 18(1):9-17. PubMed ID: 11489218
[TBL] [Abstract][Full Text] [Related]
17. First-trimester nuchal translucency: a risk analysis on fetal chromosome abnormality.
van Vugt JM; van Zalen-Sprock RM; Kostense PJ
Radiology; 1996 Aug; 200(2):537-40. PubMed ID: 8685353
[TBL] [Abstract][Full Text] [Related]
18. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
Chen X; Chang Y; Cui HY; Ren CC; Yu BY
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
[TBL] [Abstract][Full Text] [Related]
19. Ultrasonographic measurement of fetal nuchal skin to screen for chromosomal abnormalities.
Watson WJ; Miller RC; Menard MK; Chescheir NC; Katz VL; Hansen WF; Wolf EJ
Am J Obstet Gynecol; 1994 Feb; 170(2):583-6. PubMed ID: 8116717
[TBL] [Abstract][Full Text] [Related]
20. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
